Participation in EDF-2026 Call - EDF-2026-RA-MCBRN-DST: CBRN decontamination systems and technologies

What do we offer?

We can offer Pharma-Grade Precision for Autonomous CBRN Decontamination.

With 20 years of experience in the GMP-regulated pharmaceutical and medical sectors, we offer the technical expertise to support bridging the gap between chemical research and robust, field-ready hardware for the EDF-2026-RA-MCBRN-DST call.

• Validated Cleaning (CIP/WIP): We adapt proven Clean-In-Place (CIP) technologies to varying customized requirements & platforms. This ensures the thorough, validated cleaning of complex geometries and / or sensitive products.

• Precision & Material Protection: Leveraging our cleanroom heritage, we specialize in the gentle yet effective treatment of high-tech components.

  • Design & Construction: Thorough experience in designing and building turn-key cleanrooms (ISO/GMP)

  • Contamination Control: Advanced knowledge in airflow, pressure differentials, and containment

  • VHP Compatibility: Expert in systems resistant to Vaporized Hydrogen Peroxide and other aggressive sterilants as well as protective gas atmospheres

• Modular Machinery – Designed for Flexibility

  • Modular Architecture: Our systems are built on standardized, scalable modules (Mechanical, Electrical, Software)

  • R&D Power: High development competence in creating entirely new automated processes from scratch

  • Prototyping: Rapid transition from concept to TRL 6-ready industrial solutions.

What are we looking for?

Strategic Partnerships to Bridge the Gap Between CBRN Research and Hardware Integration.

To maximize the impact of the EDF-2026-RA-MCBRN-DST call, we are seeking to join a consortium as a Technology Partner and Hardware Integrator. Specifically, we are looking for:

• Consortium Leads (Large System Integrators): Prime contractors or large defense companies looking for a specialized SME to design and manufacture the physical decontamination modules and robotic sub-systems.

• CBRN Research Institutes & Academia: Partners providing the chemical, biological, or radiological expertise who require a professional engineering firm to translate their laboratory-scale findings into TRL 4-6 functional prototypes.

• DST Software Developers: Collaborators developing the Decision Support Tools, who need smart, sensor-integrated hardware to provide real-time data-feeds and process validation.

• Military End-Users: Contacts within Ministries of Defence (MoDs) or CBRN defense units to provide operational requirements and feedback for our automated cleaning and robotic prototypes.

Our Goal: To contribute our 20 years of pharma-grade engineering to a multidisciplinary team, ensuring that the next generation of European CBRN decontamination systems is autonomous, material-safe, and fully validated.

What is your role in the project?

We act as the Industrial Integrator, translating advanced CBRN research into validated, field-ready hardware.

Within the EDF-2026-RA-MCBRN-DST framework, our role is to bridge the gap between theoretical decontamination concepts and operational machinery. Leveraging our 20-year background in the pharmaceutical sector, we take responsibility for:

• Work Package Lead/Support for Hardware Prototyping: Designing and manufacturing the physical decontamination units, ensuring they meet rigorous industrial and military standards.

• Automation & Robotics Integration: Implementing the mechanical systems and control software required for autonomous spray cycles and robotic handling of sensitive equipment.

• Process Validation & Data Provisioning: Installing the sensor arrays necessary to monitor decontamination success in real-time, providing the critical data-feed for the Decision Support Tool (DST).

• GMP-Standardization of Decon Protocols: Applying pharmaceutical "Clean-In-Place" (CIP) logic to ensure that every decontamination cycle is repeatable, documented, and safe for sensitive high-tech materials.

In essence: We are the engineering engine of the consortium, ensuring that the research outcomes result in a functional, scalable, and fully validated prototype (TRL 4-6).